Literature DB >> 4040783

A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A.

P W Koppert, C M Huijsmans, W Nieuwenhuizen.   

Abstract

Spleen cells of BALB/c mice, immunized with fragments Y of normal human fibrinogen, were fused with P3 X 63 Ag 8653 myeloma cells. A clone was found which produces monoclonal antibodies (Mab-Y18) of the IgM kappa type. Mab-Y18 is immunoreactive with normal human fibrinogen, and its fragments X, Y, N-terminal disulphide knot, A alpha-chain, and A alpha stretch 1-51. The immunoreactivity with these same fragments disappears upon treatment with thrombin or arvin. This strongly suggests that fibrinopeptide A is an essential component of the Mab-Y18 epitope. This is supported by the finding that Mab-Y18 prolongs the thrombin and arvin clotting times of human fibrinogen by inhibition of the fibrinopeptide A release. More detailed information about the nature of the Mab-Y18 epitope was obtained from studies with genetic variants of human fibrinogen (especially fibrinogen Metz) and with fibrinogens from other mammalian species. These studies show that amino acid residue A alpha 16 (arginine) of fibrinopeptide A is essential for the Mab-Y18 epitope. Mab-Y18 does not react with free fibrinopeptide A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040783

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Polymerization of rod-like macromolecular monomers studied by stopped-flow, multiangle light scattering: set-up, data processing, and application to fibrin formation.

Authors:  S Bernocco; F Ferri; A Profumo; C Cuniberti; M Rocco
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  Substitution of the human αC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers.

Authors:  Lifang Ping; Lihong Huang; Barbara Cardinali; Aldo Profumo; Oleg V Gorkun; Susan T Lord
Journal:  Biochemistry       Date:  2011-09-27       Impact factor: 3.162

Review 3.  New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.

Authors:  W Nieuwenhuizen
Journal:  Blut       Date:  1988-11

4.  The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies.

Authors:  W J Schielen; M Voskuilen; G I Tesser; W Nieuwenhuizen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.

Authors:  J Koopman; F Haverkate; J Grimbergen; S T Lord; M W Mosesson; J P DiOrio; K S Siebenlist; C Legrand; J Soria; C Soria
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.

Authors:  J Koopman; F Haverkate; J Grimbergen; L Engesser; I Nováková; A F Kerst; S T Lord
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.

Authors:  D Rouy; E Anglés-Cano
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

8.  Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.

Authors:  Silja Vorjohann; Richard J Fish; Christine Biron-Andréani; Chandrasekaran Nagaswami; John W Weisel; Pierre Boulot; Lionel Reyftmann; Philippe de Moerloose; Marguerite Neerman-Arbez
Journal:  Thromb Haemost       Date:  2010-08-30       Impact factor: 5.249

9.  Hydrodynamic characterization of recombinant human fibrinogen species.

Authors:  Bertrand Raynal; Barbara Cardinali; Jos Grimbergen; Aldo Profumo; Susan T Lord; Patrick England; Mattia Rocco
Journal:  Thromb Res       Date:  2013-04-30       Impact factor: 3.944

10.  Fibrinogen αC-regions are not directly involved in fibrin polymerization as evidenced by a "Double-Detroit" recombinant fibrinogen mutant and knobs-mimic peptides.

Authors:  Cédric Duval; Aldo Profumo; Anna Aprile; Annalisa Salis; Enrico Millo; Gianluca Damonte; Julia S Gauer; Robert A S Ariëns; Mattia Rocco
Journal:  J Thromb Haemost       Date:  2020-01-29       Impact factor: 5.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.